Editas Medicine, Inc.
EDIT
$1.33
-$0.21-13.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 50,070.49% | -88.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 50,070.49% | -88.11% | |||
| Cost of Revenue | 2.04% | 2,141.84% | |||
| Gross Profit | 62.15% | -2,851.49% | |||
| SG&A Expenses | -9.59% | -0.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.16% | -9.24% | |||
| Operating Income | 47.67% | 8.67% | |||
| Income Before Tax | 26.95% | 8.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 26.95% | 8.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.95% | 8.08% | |||
| EBIT | 47.67% | 8.67% | |||
| EBITDA | 48.52% | 9.10% | |||
| EPS Basic | 27.06% | 8.28% | |||
| Normalized Basic EPS | 46.71% | 8.30% | |||
| EPS Diluted | 27.06% | 8.28% | |||
| Normalized Diluted EPS | 46.71% | 8.30% | |||
| Average Basic Shares Outstanding | 0.16% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||